4-((4-Chloropyrimidin-2-yl)amino)benzonitrile, 95.0%, 10g

3-(3-Aminopropyl)-1-methyl-1H-imidazol-3-ium chloride, 98%, 1g

Methyl 2-(benzyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

2-(PYRIDIN-3-YLOXY)ETHANAMINE HCL, 95.0%, 250mg

2-(2,6-Dioxopiperidin-3-yl)-4,5-difluoroisoindoline-1,3-dione, 250mg

2-CHLORO-4-(3-FLUORO-BENZYLOXY)ANILINE, 95.0%, 1g

Infinity corrected semi plan SMP 10x/0.25 IOS objective. Working distance 5.95 mm

Ethyl 3-chloro-5H,6H,7H,8H-pyrido[4,3-c]pyridazine-6-carboxylate, 98%, 1g

N-NITROSODIBUTYLAMINE, 95%, 100mg

(1S,2R,4S,5R)-2-((S)-Hydroxy(quinolin-4-yl)methyl)-1-(4-(trifluoromethyl)benzyl)-5-vinylquinuclidin-1-ium bromide, 98%, 1g

2-Chloro-3-methyl-5-pyridineboronic acid, 95.0%, 5g

4-Bromo-N,N,3-trimethylaniline>98.0%(GC)(T)25g

3-Fluoro-5-(pentafluorosulfur)phenylacetic acid, 1g